Product Code: ETC6183361 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Australias market for irritable bowel syndrome treatment is shaped by a wide array of pharmaceutical and non-pharmaceutical solutions. The treatment landscape includes prescription drugs, over-the-counter medications, dietary supplements, and psychological therapies. Increasing investment in research and clinical trials for novel therapies is enhancing treatment options. Government healthcare programs and the Pharmaceutical Benefits Scheme (PBS) provide some level of support for patients, but rising costs remain a concern for long-term treatment adherence.
Australias IBS treatment market is expanding in tandem with the broader IBS diagnosis trends. There is a noticeable shift toward personalized treatment approaches based on symptom subtype (constipation-predominant, diarrhea-predominant, or mixed). The demand for low FODMAP diet plans, gut-directed hypnotherapy, and advanced drug formulations like linaclotide and rifaximin is on the rise. Pharmaceutical companies and wellness brands alike are focusing on holistic treatment combinations that include stress reduction therapies and dietary supplements.
The Australia irritable bowel syndrome treatment market faces hurdles such as the need for more personalized and holistic treatment approaches. Many patients turn to alternative medicine, and pharmaceutical companies must navigate the limited effectiveness of current drugs alongside the need for innovation without significant side effects.
The treatment-specific market for IBS in Australia is attractive due to advancements in pharmaceutical and natural therapy options. Demand for low FODMAP diet products, non-invasive therapies, and over-the-counter medications continues to grow. Investors may focus on product innovation, clinical trials for new drug approvals, and partnerships with gastroenterology clinics. Digital therapeutics and mobile health apps for symptom tracking and personalized treatment also offer emerging investment channels.
IBS treatment is regulated under Australia`s Pharmaceutical Benefits Scheme (PBS), which subsidizes certain medications. The Therapeutic Goods Administration (TGA) ensures that only safe and effective IBS treatments are available on the market, impacting product approval and market dynamics.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Irritable Bowel Syndrome Treatment Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Irritable Bowel Syndrome Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Irritable Bowel Syndrome Treatment Market - Industry Life Cycle |
3.4 Australia Irritable Bowel Syndrome Treatment Market - Porter's Five Forces |
3.5 Australia Irritable Bowel Syndrome Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Irritable Bowel Syndrome Treatment Market Revenues & Volume Share, By Product, 2021 & 2031F |
4 Australia Irritable Bowel Syndrome Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Irritable Bowel Syndrome Treatment Market Trends |
6 Australia Irritable Bowel Syndrome Treatment Market, By Types |
6.1 Australia Irritable Bowel Syndrome Treatment Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Irritable Bowel Syndrome Treatment Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Irritable Bowel Syndrome Treatment Market Revenues & Volume, By IBS-C, 2021- 2031F |
6.1.4 Australia Irritable Bowel Syndrome Treatment Market Revenues & Volume, By IBS-D, 2021- 2031F |
6.2 Australia Irritable Bowel Syndrome Treatment Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Australia Irritable Bowel Syndrome Treatment Market Revenues & Volume, By Xifaxan, 2021- 2031F |
6.2.3 Australia Irritable Bowel Syndrome Treatment Market Revenues & Volume, By Linzess/Constella, 2021- 2031F |
6.2.4 Australia Irritable Bowel Syndrome Treatment Market Revenues & Volume, By Viberzi, 2021- 2031F |
6.2.5 Australia Irritable Bowel Syndrome Treatment Market Revenues & Volume, By Amitiza, 2021- 2031F |
6.2.6 Australia Irritable Bowel Syndrome Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Irritable Bowel Syndrome Treatment Market Import-Export Trade Statistics |
7.1 Australia Irritable Bowel Syndrome Treatment Market Export to Major Countries |
7.2 Australia Irritable Bowel Syndrome Treatment Market Imports from Major Countries |
8 Australia Irritable Bowel Syndrome Treatment Market Key Performance Indicators |
9 Australia Irritable Bowel Syndrome Treatment Market - Opportunity Assessment |
9.1 Australia Irritable Bowel Syndrome Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Irritable Bowel Syndrome Treatment Market Opportunity Assessment, By Product, 2021 & 2031F |
10 Australia Irritable Bowel Syndrome Treatment Market - Competitive Landscape |
10.1 Australia Irritable Bowel Syndrome Treatment Market Revenue Share, By Companies, 2024 |
10.2 Australia Irritable Bowel Syndrome Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |